Amphastar Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 9,392 | 0.0% | 350,707 | 12/31/2025 |
| 2025 Q3 | 11/10/2025 | 9,498 | 0.0% | 356,409 | 9/30/2025 |
| 2025 Q2 | 8/12/2025 | 7,962 | 0.0% | 346,784 | 6/30/2025 |
| 2025 Q1 | 9/15/2025 | 9,457 | 0.0% | 326,226 | 3/31/2025 |
| 2024 Q4 | 2/6/2025 | 12,903 | 0.0% | 347,512 | 12/31/2024 |
| 2024 Q3 | 11/12/2024 | 16,988 | 0.0% | 350,056 | 9/30/2024 |
| 2024 Q2 | 8/12/2024 | 14,369 | 0.0% | 359,222 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 15,650 | 0.0% | 356,405 | 3/31/2024 |
| 2023 Q4 | 2/6/2024 | 23,471 | 0.0% | 379,480 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 16,206 | 0.0% | 352,378 | 9/30/2023 |
| 2023 Q2 | 8/10/2023 | 18,865 | 0.0% | 328,262 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 12,372 | 0.0% | 329,913 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 9,157 | 0.0% | 326,788 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 8,635 | 0.0% | 307,293 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 10,952 | 0.0% | 314,793 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 9,636 | 0.0% | 268,398 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 6,078 | 0.0% | 260,935 | 12/31/2021 |
| 2021 Q3 | 11/16/2021 | 4,805 | 0.0% | 252,767 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 5,109 | 0.0% | 253,387 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 4,542 | 0.0% | 247,899 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 4,870 | 0.0% | 242,148 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 4,447 | 0.0% | 237,132 | 9/30/2020 |
| 2020 Q2 | 8/20/2020 | 5,124 | 0.0% | 228,101 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 3,267 | 0.0% | 220,092 | 3/31/2020 |
| 2019 Q4 | 2/7/2020 | 4,169 | 0.0% | 216,109 | 12/31/2019 |